Loading...
Varex Imaging Corporation
VREX•NASDAQ
Healthcare
Medical - Devices
$7.85
$0.30(3.97%)
Varex Imaging Corporation (VREX) Financial Performance & Income Statement Overview
Review Varex Imaging Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-9.22%
↓ 9.22%
Operating Income Growth
-58.37%
↓ 58.37%
Net Income Growth
-198.96%
↓ 198.96%
Operating Cash Flow Growth
-56.37%
↓ 56.37%
Operating Margin
6.47%
↑ 6.47%
Gross Margin
33.74%
↑ 33.74%
Net Profit Margin
-5.08%
↓ 5.08%
ROE
-7.61%
↓ 7.61%
ROIC
4.50%
↑ 4.50%
Varex Imaging Corporation (VREX) Income Statement & Financial Overview
Review Varex Imaging Corporation's (VREX) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $199.80M | $205.70M | $209.10M | $206.20M |
| Cost of Revenue | $131.30M | $138.60M | $142.20M | $140.40M |
| Gross Profit | $68.50M | $67.10M | $66.90M | $65.80M |
| Gross Profit Ratio | $0.34 | $0.33 | $0.32 | $0.32 |
| R&D Expenses | $23.50M | $21.90M | $22.00M | $22.60M |
| SG&A Expenses | $33.80M | $34.30M | $35.60M | $35.50M |
| Operating Expenses | $57.30M | $56.20M | $57.60M | $58.10M |
| Total Costs & Expenses | $188.60M | $194.80M | $199.80M | $198.50M |
| Interest Income | $2.10M | $1.80M | $1.80M | $1.80M |
| Interest Expense | $8.20M | $7.80M | $7.60M | $6.70M |
| Depreciation & Amortization | $7.10M | $6.60M | $7.00M | $8.80M |
| EBITDA | $17.80M | $16.90M | $16.30M | $16.50M |
| EBITDA Ratio | $0.09 | $0.08 | $0.08 | $0.08 |
| Operating Income | $11.20M | $10.90M | $9.30M | $7.70M |
| Operating Income Ratio | $0.06 | $0.05 | $0.04 | $0.04 |
| Other Income/Expenses (Net) | -$8.70M | -$8.40M | -$8.50M | -$5.40M |
| Income Before Tax | $2.50M | $2.50M | $800000.00 | $2.30M |
| Income Before Tax Ratio | $0.01 | $0.01 | $0.004 | $0.01 |
| Income Tax Expense | $2.60M | $52.40M | -$700000.00 | $700000.00 |
| Net Income | -$300000.00 | -$50.00M | $1.40M | $1.40M |
| Net Income Ratio | -$0.002 | -$0.24 | $0.007 | $0.007 |
| EPS | -$0.007 | -$1.23 | $0.03 | $0.03 |
| Diluted EPS | -$0.007 | -$1.23 | $0.03 | $0.03 |
| Weighted Avg Shares Outstanding | $41.10M | $40.80M | $40.90M | $40.70M |
| Weighted Avg Shares Outstanding (Diluted) | $41.10M | $40.80M | $41.20M | $41.20M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan